![David Berman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 212 799 $ al 31/08/2026
David Berman is Chief Development Officer at Moderna, Inc. since 2026.
Formerly, Dr. Berman was Executive VP & Head-Research & Development at Immunocore Holdings Plc from 2019 to 2026, Head-Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018, Head-Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and Head-Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from The University of Texas Southwestern Medical Center.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUNOCORE HOLDINGS PLC 0,01 % | 02/04/2026 | 5.859 ( 0,01 % ) | 212 799 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 02/03/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Director Técnico/Científico/I+D | 27/02/2026 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2018 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01/01/2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
